MedTrace Logo

Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus

NCT04412798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-05-17

No results posted yet for this study

Summary

The evidence on the consumption of 100% orange juice in people with type 2 diabetes is highly variable and largely out-of-date, with a few studies reporting acute negative glycaemic effects when 100% orange juice is drunk with or without a meal. The aim of the project is to study the impact of the intake of a single serving of 100% orange juice on glycaemic control in male patients with pre-existing type 2 diabetes mellitus. In addition, immunological parameters and Alzheimer disease related biomarkers will be assessed to examine the chronic inflammatory state of these patients

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

orange juice concentrate

250mL of 100% orange juice made from concentrate

OTHER

Sugar-sweetened orange-flavoured beverage

Sugar-sweetened orange-flavoured beverage, energy-matched to the orange juice condition

OTHER

Whole orange juice with skin removed

Whole orange pieces with skin removed, energy-matched to the orange juice condition

Sponsors & Collaborators

  • Hochschule Geisenheim University

    collaborator UNKNOWN

  • Hasselt University

    lead OTHER

Principal Investigators

  • Dominique Hansen, prof. dr. · Hasselt University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04412798 on ClinicalTrials.gov